【PharmaEssentia】February 2026 Revenue Reaches 1.60 Billion (YoY +56.7%)
NQ Score
67/100
N1 Content Completeness
4
AI Summary (NQ-processed)
PharmaEssentia, a new drug development company, announced that its revenue for February 2026 reached 1.60 billion, a year-over-year increase of 56.7%. This strong performance is primarily attributed to the sales of its new drug for treating polycythemia vera, highlighting its success in the biotechnology and healthcare market.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What was PharmaEssentia's revenue in February 2026?
- A: PharmaEssentia's revenue in February 2026 reached 1.60 billion NTD.
- Q: How much did PharmaEssentia's revenue increase year-over-year in February 2026?
- A: PharmaEssentia's revenue saw a year-over-year increase of 56.7% in February 2026.
- Q: What is the stock code for PharmaEssentia Corp.?
- A: The stock code for PharmaEssentia Corp. is 6446.
- Q: In which industry does PharmaEssentia Corp. operate?
- A: PharmaEssentia Corp. operates in the Biotechnology & Medical Care industry.
- Q: What was the exact monthly revenue figure for PharmaEssentia in February 2026, in thousands of NTD?
- A: The exact monthly revenue figure for PharmaEssentia in February 2026 was 1,600,454 thousand NTD.